Clinical Trial Detail

NCT ID NCT02407171
Title Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Yale University
Indications

lung non-small cell carcinoma

melanoma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.